Literature DB >> 16515652

Evaluation of IgG subclass responses against Dermatophagoides farinae allergens in healthy and atopic dogs.

Chia-Chun Hou1, Michael J Day, Timothy J Nuttall, Peter B Hill.   

Abstract

A semiquantitative chemiluminescent Western blot analysis system was developed and validated to evaluate antigen-specific IgG subclass responses to electrophoretically separated proteins of Dermatophagoides farinae in healthy and atopic dogs. Both groups mounted similar D. farinae-specific IgG1 and IgG4 responses to multiple antigens, but IgG2 and IgG3 responses were difficult to detect. The most commonly recognized bands in both groups were 18 and 98 kDa antigens for IgG1 and 18, 45, 66, 98, 130 and 180 kDa for IgG4. The number of bands recognized per dog did not differ significantly, but significantly more atopic dogs had an IgG1 response to a 180 kDa protein. The overall D. farinae-specific IgG1 and IgG4 responses were slightly higher, but not significantly different, in the healthy group. The results suggest that some antigens produced by D. farinae can induce different subclass responses. However, as most of these responses are seen in both healthy and atopic dogs, they are likely to merely represent recognition of foreign proteins presented to the immune system, rather than involvement in the pathogenesis of atopic dermatitis. The role of the 180 kDa antigen warrants further study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515652     DOI: 10.1111/j.1365-3164.2006.00509.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  2 in total

1.  Immunoglobulin G1 subclass responses can be used to detect specific allergy to the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus in atopic dogs.

Authors:  N Khantavee; C Chanthick; A Tungtrongchitr; N Techakriengkrai; S Suradhat; N Sookrung; S Roytrakul; N Prapasarakul
Journal:  BMC Vet Res       Date:  2021-02-05       Impact factor: 2.741

Review 2.  Hemozoin inhibition and control of clinical malaria.

Authors:  Chibueze Peter Ihekwereme; Charles Okechukwu Esimone; Edward Chieke Nwanegbo
Journal:  Adv Pharmacol Sci       Date:  2014-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.